NSCLC
The ALK inhibitor presented in this study is effective in EML4-ALK NSCLC cases.
The <span class="gene" id="21757253-17-4-7">ALK</span> inhibitor presented in this study is effective in EML4-<span class="gene" id="21757253-17-63-66">ALK</span> <span class="disease" id="21757253-17-67-72">NSCLC</span> cases.